Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Drug Delivery Science and Technology"
DOI: 10.1016/j.jddst.2020.101790
Abstract: Abstract Parkinson's disease (PD), although being the second most prevalent neurodegenerative disease (ND) encounters lack of definitive treatment and challenges in drug delivery. There are enormous factors provoking degeneration of neurons in the substantia nigra… read more here.
Keywords: disease current; drug delivery; delivery; drug ... See more keywords
Safety of the current drug treatments for vitiligo
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2020.1729737
Abstract: ABSTRACT Introduction: Vitiligo is an acquired depigmenting skin disorder adversely affecting the patient’s quality of life. Despite the presence of several treatment modalities, ranging from medical to physical to surgical options, none is curative. Each… read more here.
Keywords: drug treatments; treatment; safety; safety current ... See more keywords
Bibliometric Analysis of Current Drug Metabolism: The Twenty Years Anniversary From 2000-2019.
Sign Up to like & getrecommendations! Published in 2020 at "Current drug metabolism"
DOI: 10.2174/1389200221666200826094233
Abstract: BACKGROUND Scopus is regularly covering Current Drug Metabolism from 2000 onwards. OBJECTIVE The major objective is to perform the 1st bibliometric analysis of Current Drug Metabolism (CDM). METHODS The data was retrieved from Scopus in… read more here.
Keywords: metabolism; bibliometric analysis; drug; drug metabolism ... See more keywords
Current Drug Targets (CDT) special issue on Covid-19 and Coagulopathy Fibrinolysis in COVID-19: impact on clot lysis and modulation of inflammation.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug targets"
DOI: 10.2174/1389450123666221011102250
Abstract: COVID-19 is a multisystem disease caused by SARS-CoV-2 and is associated with an imbalance between the coagulation and fibrinolytic systems. Systemically, hypercoagulation, hypofibrinolysis and fibrin-clot resistance to fibrinolysis predispose patients to thrombotic and thromboembolic events.… read more here.
Keywords: inflammation; coagulation; fibrinolysis; current drug ... See more keywords
Impact evaluations of articles in Current Drug Delivery based on Web of Science.
Sign Up to like & getrecommendations! Published in 2023 at "Current drug delivery"
DOI: 10.2174/1567201820666230508115356
Abstract: A total of 1534 and 308 articles were published in the journal Current Drug Delivery (CDD), from 2004 and 2019 to 2021, respectively. In this commentary, their impacts were analyzed based on search data about… read more here.
Keywords: current drug; web science; drug; drug delivery ... See more keywords
Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232315114
Abstract: Post-stroke depression (PSD) is a biopsychosocial disorder that affects individuals who have suffered a stroke at any point. PSD has a 20 to 60 percent reported prevalence among stroke survivors. Its effects are usually adverse,… read more here.
Keywords: psd; current drug; stroke depression; pathophysiology current ... See more keywords